Founded in 2008, Eiger BioPharmaceuticals is a late-stage biopharmaceutical company focused on developing and commercializing targeted therapies for rare diseases.
Recent acquisitions and investments have considerably enlarged Croda's presence in Brazil both in manufacturing and in R&D with its new innovation center at Campinas.